In vitro maturation in polycystic ovary syndrome and poor responders - Effect of follicular size and FSH concentration in culture media

被引:0
|
作者
Elbarbary, Yousif [1 ]
Samy, Mahmoud [2 ]
Ibrahim, Hythum Y. [3 ]
机构
[1] Almana Gen Hosp, Al Khobar, Saudi Arabia
[2] Homboldt Univ, Benjamin Franklin Charite, Berlin, Germany
[3] Heartlands Hosp, Birmingham, W Midlands, England
来源
WORLD FAMILY MEDICINE | 2007年 / 5卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: - To determine the effect of recombinant Follicle Stimulating Hormone (r-FSH) concentration in culture media on in vitro maturation outcomes. - To determine the effect of the follicle size on in vitro maturation outcomes. - To determine the in vitro maturation outcomes of immature oocytes recovered from infertile patients with polycystic ovaries (PCO) and poor responders. Design & Methods: Two-stage prospective study was performed in an IVF unit in the eastern province of Saudi Arabia. The first stage compared the fertilization and pregnancy outcomes in patients with Polycystic Ovary (PCO) Syndrome and patients with poor response to recombinant Follicular Stimulation Hormone (rFSH). The second compared these outcomes according to follicular size. Oocytes retrieved after 5 days rFSH course were divided into two groups according to follicular size (8-10mm and 1113mm) and were cultured in a 0.075 IU/ml medium.. The effect of follicular size on oocytes-maturation, fertilization, embryo cleavage, and pregnancy rate was assessed in the two groups and in those with PCO and poor responders. Results: There was no difference in the main outcome measures between oocytes cultured in the two concentrations of FSH. Oocytes retrieved from 11-13 mm follicles showed higher rates of maturation, fertilization and pregnancy, than those retrieved from 8-10 mm follicles. In both PCO and poor responders patients embryos produced from regularly cycling patients had a significantly higher embryo development ratio, even though cleavage was not significantly different. Conclusion: Concentrations higher than 0.075 IU ml in culture media for IVM are not necessarily associated with better outcomes. Larger follicular size produces better fertilization and pregnancy rates. In both PCO and poor responders, cycle irregularity is associated with poorer outcomes.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 50 条
  • [41] NON INVASIVE PREDICTION OF OVARIAN HYPER STIMULATION SYNDROME RISK IN POLYCYSTIC OVARY SYNDROME (PCOS) AND HYPER RESPONDERS BY FOLLICULAR FLUID METABOLOMICS.
    Cordeiro, F. B.
    Cataldi, T. R.
    Teixeira da Costa, L. D.
    Victorino, A. B.
    Cedenho, A. P.
    Lo Turco, E. G.
    FERTILITY AND STERILITY, 2016, 106 (03) : E259 - E259
  • [42] Effect of hormones, follicular fluid, serum and media on in vitro maturation of porcine oocyte
    Kumar, Suresh
    Gedam, Sonal
    Biswas, R. K.
    Purkayastha, A.
    Devi, Bhanita
    Bharti, P. K.
    Doley, S.
    Kadirvel, G.
    INDIAN JOURNAL OF ANIMAL SCIENCES, 2015, 85 (09): : 958 - 961
  • [43] In vitro maturation of equine oocytes: Effect of follicular size, cyclic stage and season
    Bruck, I
    Grondahl, C
    Host, T
    Greve, T
    THERIOGENOLOGY, 1996, 46 (01) : 75 - 84
  • [44] Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization
    Niu, Zhihong
    Ye, Yao
    Xia, Lan
    Feng, Yun
    Zhang, Aijun
    CYTOKINE, 2017, 91 : 180 - 186
  • [45] Comment on comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis
    Wu, Jiangfeng
    Ge, Lifang
    Chen, Qiaoqian
    Zhao, Anli
    Guo, Yinghong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (09)
  • [46] Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome
    Ma, Rujun
    Wang, Shuxian
    Xue, Mengqi
    Zhang, Hong
    He, Zhaowanyue
    Jueraitetibaike, Kadiliya
    Ge, Xie
    Chen, Li
    Yao, Bing
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [47] Clinical observation of treatment for polycystic ovary syndrome patients with hormonal priming by in vitro maturation of oocytes.
    Wu, X. C.
    Cao, Y. X.
    Zhang, Z. G.
    Zhao, J. H.
    FERTILITY AND STERILITY, 2006, 86 : S390 - S391
  • [48] Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome
    De Vos, Michel
    Ortega-Hrepich, Carolina
    Albuz, Firas K.
    Guzman, Luis
    Polyzos, Nikolaos P.
    Smitz, Johan
    Devroey, Paul
    FERTILITY AND STERILITY, 2011, 96 (04) : 860 - U309
  • [49] In vitro growth and maturation of isolated caprine preantral follicles: Influence of insulin and FSH concentration, culture dish, coculture, and oocyte size on meiotic resumption
    Silva, G. M.
    Brito, I. R.
    Sales, A. D.
    Aguiar, F. L. N.
    Duarte, A. B. G.
    Araujo, V. R.
    Vieira, L. A.
    Magalhaes-Padilha, D. M.
    Lima, L. F.
    Alves, B. G.
    Silveira, L. B. R.
    Lo Turco, E. G.
    Rodrigues, A. P.
    Campello, C. C.
    Wheeler, M. B.
    Figueiredo, J. R.
    THERIOGENOLOGY, 2017, 90 : 32 - 41
  • [50] DOES OVARIAN MORPHOLOGY AFFECT THE REPRODUCTIVE OUTCOMES OF IN-VITRO MATURATION CYCLES IN POLYCYSTIC OVARY SYNDROME?
    Tannus, Samer
    Elizur, Shai E.
    Tan, Seang Lin
    Son, Weon-Young
    Dahan, Michael H.
    FERTILITY AND STERILITY, 2021, 116 (03) : E126 - E126